Evidence map›Paper›PMID 34853057›Full record

ArticleGut2022

RNA binding protein DDX5 directs tuft cell specification and function to regulate microbial repertoire and disease susceptibility in the intestine.

Tianyun Long, Nazia Abbasi, Juan E Hernandez, Yuxin Li, Ibrahim M Sayed, Shengyun Ma, Attilio Iemolo, Brian A Yee, Gene W Yeo, Francesca Telese and 3 more

Open access · greenAbstract read
In one paragraph

Article in Gut, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Tuft Cells in the Gut Limit Cognitive Disorders by Regulating Gut Homeostasis.Cellular and molecular gastroenterology and hepatology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Tuft cells in the intestine, immunity and beyond.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Tianyun LongDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Nazia AbbasiDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Juan E HernandezDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Yuxin LiDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Ibrahim M SayedDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
Shengyun MaDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Attilio IemoloDepartment of Medicine, University of California, San Diego, La Jolla, California, USA.
Brian A YeeDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Francesca TeleseDepartment of Medicine, University of California, San Diego, La Jolla, California, USA.
Pradipta GhoshDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Soumita DasDepartment of Pathology, University of California San Diego, La Jolla, California, USA.
Wendy Jia Men HuangDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA wjh003@ucsd.edu.ORCID 0000-0001-7425-8280
University of California San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
Spatial Regulation of RGS and G Protein SignalingR01CA100768 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2003 to 2019
$7.4M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Modulation of Macrophage Polarization by Heterotrimeric G proteins: Implications of Gastrointestinal InflammationR01AI141630 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Pradipta Ghosh · 2019 to 2026
$3.2M
Integrators of Metastatic PotentialR01CA238042 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA, LUKER, GARY D · 2019 to 2023
$2.3M
Innate responses following infection with enteric microbesR01DK107585 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAS, SOUMITA · 2016 to 2020
$2.2M
Post-translational modifications in RORgt-dependent immune cell functionsR01GM124494 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HUANG, WENDY JIA MEN · 2017 to 2021
$2.0M
Modulation of G proteins by Growth FactorsR01CA160911 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2013 to 2017
$1.8M
Network-Based Novel Therapeutics in Colorectal CancersUG3TR002968 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAS, SOUMITA, GHOSH, PRADIPTA · 2019 to 2021
$946k
Precision therapeutics of inflammatory bowel disease guided by Boolean logicUG3TR003355 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAS, SOUMITA, GHOSH, PRADIPTA · 2020 to 2022
$937k
NCATS NIH HHS UG3 TR002968NCATS NIH HHS UG3 TR003355NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA100768NCI NIH HHS R01 CA160911NCI NIH HHS R01 CA238042NCI NIH HHS T32 CA067754NIAID NIH HHS R01 AI141630NIDDK NIH HHS R01 DK107585NIGMS NIH HHS R01 GM124494
6 · The paper itself

Abstract

objectiveTuft cells residing in the intestinal epithelium have diverse functions. In the small intestine, they provide protection against inflammation, combat against helminth and protist infections, and serve as entry portals for enteroviruses. In the colon, they had been implicated in tumourigenesis. Commitment of intestinal progenitor cells to the tuft cell lineage requires Rho GTPase Cell Division Cycle 42 (CDC42), a Rho GTPase that acts downstream of the epidermal growth factor receptor and wingless-related integration site signalling cascades, and the master transcription factor POU class 2 homeobox 3 (POU2F3). This study investigates how this pathway is regulated by the DEAD box containing RNA binding protein DDX5 in vivo.

designWe assessed the role of DDX5 in tuft cell specification and function in control and epithelial cell-specific

resultsDDX5

conclusionRNA binding protein DDX5 directs tuft cell specification and function to regulate microbial repertoire and disease susceptibility in the intestine.

Indexed as

Intestinal MucosaAnimalsCarcinogenesisDEAD-box RNA HelicasesDisease SusceptibilityInflammationMicerho GTP-Binding ProteinsRNA-Binding ProteinsDdx5 protein, mouseDEAD-box RNA Helicasesrho GTP-Binding ProteinsRNA-Binding Proteinscolon carcinogenesisepithelial differentiationgut inflammationsmall intestine

Identifiers

PMID34853057
PMCPMC9156727
OpenAlexW3215965634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.